Mosaic mutations in early-onset genetic diseases.

2016-07

Halvorsen, Matt

Petrovski, Slavé

Shellhaas, Renée

Tang, Yingying

Crandall, Laura

Goldstein, David

Devinsky, Orrin

Journal Article

0000-0002-1527-961X

10.1038/gim.2015.155

An emerging approach in medical genetics is to identify de novo mutations in patients with severe early-onset genetic disease that are absent in population controls and in the patient's parents. This approach, however, frequently misses post-zygotic "mosaic" mutations that are present in only a portion of the healthy parents' cells and are transmitted to offspring. We constructed a mosaic transmission screen for variants that have an ~50% alternative allele ratio in the proband but are significantly less than 50% in the transmitting parent. We applied it to two family-based genetic disease cohorts consisting of 9 cases of sudden unexplained death in childhood (SUDC) and 338 previously published cases of epileptic encephalopathy. The screen identified six parental-mosaic transmissions across the two cohorts. The resultant rate of ~0.02 identified transmissions per trio is far lower than that of de novo mutations. Among these transmissions were two likely disease-causing mutations: an SCN1A mutation transmitted to an SUDC proband and her sibling with Dravet syndrome, as well as an SLC6A1 mutation in a proband with epileptic encephalopathy. These results highlight explicit screening for mosaic mutations as an important complement to the established approach of screening for de novo mutations.Genet Med 18 7, 746-749.

link

Genetics in medicine : official journal of the American College of Medical Genetics 2016; 18(7): 746-749

Genetics in medicine : official journal of the American College of Medical Genetics